Home › Funds › Trails Edge Capital Partners, LP › CAMP

Trails Edge Capital Partners, LP position in CAMP

CAMP4 THERAPEUTICS CORP · Health Care

Trails Edge Capital Partners, LP reported holding 1,932,937 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q2 2026 13F filing — a position valued at US$8.4M, representing 1.34% of its reported portfolio and ranking #27 among its reported holdings. Trails Edge Capital Partners, LP has disclosed CAMP holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.93M sh
Reported value held$8.45M
Portfolio Weight1.34%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's CAMP position evolved

Trails Edge Capital Partners, LP first disclosed a stake in CAMP in Q4 2025 at 1,983,986 shares (US$12.2M). Across 3 filings, Trails Edge Capital Partners, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,932,937 shares valued at US$8.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.98M $12.16M New
Q1 2026 1.94M $8.55M Reduce
Q2 2026 1.93M $8.45M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAMP and 13F data

CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 37 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$18.6M), a16z Capital Management, L.L.C. (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAMP

All CAMP fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held CAMP?

Trails Edge Capital Partners, LP has disclosed CAMP holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Trails Edge Capital Partners, LP's current position in CAMP?

As of Q2 2026, Trails Edge Capital Partners, LP holds 1.93M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $8.45M, representing 1.34% of its reported portfolio and ranking #27.

Has Trails Edge Capital Partners, LP been buying or selling CAMP?

In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP held unchanged its position in CAMP.

Which other funds hold CAMP?

Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, a16z Capital Management, L.L.C., among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.